Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Richter's Syndrome (RS)

被引：10

作者：

Vaisitti, Tiziana ^{[1
]}

Jessen, Katti ^{[2
]}

Vo, Thanh-Trang ^{[2
]}

Ko, Mira ^{[2
]}

Arruga, Francesca ^{[1
]}

Vitale, Nicoletta ^{[3
]}

Braggio, Esteban ^{[4
]}

Di Napoli, Arianna ^{[5
]}

Chadburn, Amy ^{[6
]}

Allan, John N. ^{[7
]}

Furman, Richard R. ^{[7
]}

Miller, Langdon L. ^{[2
]}

Lanutti, Brian J. ^{[2
]}

Deaglio, Silvia ^{[8
]}

机构：

[1] Univ Torino, Dept Med Sci, Turin, Italy

[2] VelosBio, San Diego, CA USA

[3] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy

[4] Mayo Clin, Div Hematol Oncol, Scottsdale, AZ USA

[5] Azienda Osped Univ St Andrea, Pathol Unit, Rome, Italy

[6] Weill Cornell Med, New York, NY USA

[7] Weill Cornell Med, Div Hematol & Oncol, New York, NY USA

[8] Univ Torino, Dept Med Sci, Turin, Italy

来源：

关键词：

D O I：

10.1182/blood-2019-126827

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2856

引用

页数：3